

a16z Podcast: Move Fast But Don't Break Things (When It Comes to Computational Biology)
Jun 14, 2016
Join Vijay Pande, a16z bio fund general partner, Jeff Kindler, former Pfizer CEO, and Andrew Radin, CEO of TwoXAR, as they dissect the intersection of computation and biology. They discuss how the mindset of 'move fast' contrasts with the slow pharmaceutical landscape. Discover how cloud computing and big data revolutionize drug development, the challenges of data sharing, and the role of AI in making healthcare more affordable. The future of healthcare relies on robust data and innovative thinking!
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
Decentralizing the Pharma Landscape
01:39 • 8min
The Role of Software in Advancing Biological Research
09:15 • 2min
Embracing Big Data in Pharmaceutical Innovation
11:00 • 2min
Harnessing AI for Health: Opportunities and Challenges
12:39 • 2min
Data-Driven Innovations in Pharmaceutical Science
14:50 • 15min